Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C VanCott

Showing results (1-10 of 71) with videos related to

Pageof 8
Sort By:
Methods in Molecular Medicine|March 8, 2011
Analysis of antibody-antigen interactions using surface plasmon resonanceT C Vancott
Methods in Molecular Medicine|March 8, 2011
Analysis of Antibody Interactions with HIV-1 Envelope Expressed on the Surface of Acutely Infected H9 CellsT C Vancott, P L Hallberg
Methods in Molecular Medicine|March 8, 2011
Collection and processing of mucosal secretions from miceR W Kaminski, T C Vancott
Methods in Molecular Medicine|March 8, 2011
Collection and Processing of Mucosal Secretions from HIV-1 Infected WomenA W Artenstein, T C Vancott
JEMS : a Journal of Emergency Medical Services|June 8, 1989
Is EMS communicating with the FCC?M S Johnson, C VanCott, C Glass, et al.
Journal of Immunological Methods|February 5, 1992
Real-time biospecific interaction analysis of antibody reactivity to peptides from the envelope glycoprotein, gp160, of HIV-1T C VanCott, L D Loomis, R R Redfield, et al.
Methods in Molecular Medicine|March 8, 2011
Measurement of HIV-1 Specific and Total Antibody Secreting Cells by ELISPOTF W van Ginkel, J L Vancott, R Kaminski, et al.
Journal of Immunological Methods|June 14, 1995
Characterization of a soluble, oligomeric HIV-1 gp160 protein as a potential immunogenT C VanCott, S C Veit, V Kalyanaraman, et al.
Virology|February 9, 2000
Effects of oligomerization on the epitopes of the human immunodeficiency virus type 1 envelope glycoproteinsM K Gorny, T C VanCott, C Williams, et al.
Glycobiology|May 27, 2005
Concanavalin A binding to HIV envelope protein is less sensitive to mutations in glycosylation sites than monoclonal antibody 2G12Anastas Pashov, Stewart MacLeod, Rinku Saha, et al.
Pageof 8

Showing results (1-10 of 71) with videos related to

Sort By:
Pageof 8
Methods in Molecular Medicine|March 8, 2011
Analysis of antibody-antigen interactions using surface plasmon resonanceT C Vancott
Methods in Molecular Medicine|March 8, 2011
Analysis of Antibody Interactions with HIV-1 Envelope Expressed on the Surface of Acutely Infected H9 CellsT C Vancott, P L Hallberg
Methods in Molecular Medicine|March 8, 2011
Collection and processing of mucosal secretions from miceR W Kaminski, T C Vancott
Methods in Molecular Medicine|March 8, 2011
Collection and Processing of Mucosal Secretions from HIV-1 Infected WomenA W Artenstein, T C Vancott
JEMS : a Journal of Emergency Medical Services|June 8, 1989
Is EMS communicating with the FCC?M S Johnson, C VanCott, C Glass, et al.
Journal of Immunological Methods|February 5, 1992
Real-time biospecific interaction analysis of antibody reactivity to peptides from the envelope glycoprotein, gp160, of HIV-1T C VanCott, L D Loomis, R R Redfield, et al.
Methods in Molecular Medicine|March 8, 2011
Measurement of HIV-1 Specific and Total Antibody Secreting Cells by ELISPOTF W van Ginkel, J L Vancott, R Kaminski, et al.
Journal of Immunological Methods|June 14, 1995
Characterization of a soluble, oligomeric HIV-1 gp160 protein as a potential immunogenT C VanCott, S C Veit, V Kalyanaraman, et al.
Virology|February 9, 2000
Effects of oligomerization on the epitopes of the human immunodeficiency virus type 1 envelope glycoproteinsM K Gorny, T C VanCott, C Williams, et al.
Glycobiology|May 27, 2005
Concanavalin A binding to HIV envelope protein is less sensitive to mutations in glycosylation sites than monoclonal antibody 2G12Anastas Pashov, Stewart MacLeod, Rinku Saha, et al.
Pageof 8